Guo-rui Ruan
11 Xi Zhi Men South Street
Beijing, 100044, China
Beijing, 100044, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
Quantitative Detection of CSF3R T618I Mutation in Acute Myeloid Leukemia and Chronic Neutrophilic Leukemia Based on TaqMan-MGB Probes
Journal: Zhongguo shi yan xue ye xue za zhi
Published: June 02, 2026
Prognostic value of CEBPA bZIP signatures in cytogenetically normal acute myeloid leukaemia.
Journal: British journal of haematology
Published: January 09, 2025
Genetic Mutation Profile and Risk Stratification of Cytogenetically Normal Acute Myeloid Leukemia with CEBPA-bZIP Mutations Based on Multi-Gene Sequencing
Journal: Zhongguo shi yan xue ye xue za zhi
Published: January 01, 2025
Measurable residual disease testing by next generation sequencing is more accurate compared with multiparameter flow cytometry in adults with B-cell acute lymphoblastic leukemia.
Journal: Cancer letters
Published: January 21, 2024
Extracellular matrix protein 1 (ECM1) is a potential biomarker in B cell acute lymphoblastic leukemia.
Journal: Clinical and experimental medicine
Published: July 03, 2023
Mutations in DEAD/H-box helicase 11 correlate with increased relapse risk in adults with acute myeloid leukaemia with normal cytogenetics.
Journal: Leukemia
Published: June 19, 2023
CSRP2 transcript levels after consolidation therapy increase prognostic prediction ability in B-cell acute lymphoblastic leukaemia.
Journal: Biomolecules & biomedicine
Published: March 17, 2023
Interferon-α as maintenance therapy can significantly reduce relapse in patients with favorable-risk acute myeloid leukemia.
Journal: Leukemia & lymphoma
Published: July 01, 2021
Risk Stratification of Cytogenetically Normal Acute Myeloid Leukemia With Biallelic CEBPA Mutations Based on a Multi-Gene Panel and Nomogram Model.
Journal: Frontiers in oncology
Published: May 08, 2021
Prognostic value of RASD1 transcript levels in adult Philadelphia-negative B-cell acute lymphoblastic leukemia.
Journal: Hematology (Amsterdam, Netherlands)
Published: December 28, 2020
Osteoclast stimulatory transmembrane protein (OC-STAMP) is a promising molecular prognostic indicator for multiple myeloma.
Journal: European journal of haematology
Published: January 09, 2020
Mutation topography and risk stratification for de novo acute myeloid leukaemia with normal cytogenetics and no nucleophosmin 1 (NPM1) mutation or Fms-like tyrosine kinase 3 internal tandem duplication (FLT3-ITD).
Journal: British journal of haematology
Published: October 08, 2019
Last Updated: 09/26/2026